Biotech Values

[biotech_researcher]

"We’re seeing some decidedly low-quality IPOs recently."

To me, if the past is any guide, this probably marks the end of this great bull market in biotech. The other observation is that the biotech companies are really becoming exceedingly good at developing products that actually obtain approval from the FDA and In the EU. Over the medium term (never mind the long term) this should prove to be detrimental as too many approved compounds will be chasing fewer and fewer dollars available. First oil and commodities, next other sectors in a rotating type of deflation.